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Rosmarinus officinalis, which belongs to the Lamiaceae family, is a species of medicinal flora with 
therapeutic properties. In order to exploit the benefits of these properties, a mouthwash formulation was 
developed, with careful selection of raw materials to meet pharmacotechnical requirements. Extracts 
of the plant were incorporated into a mouthwash, which was shown to have inhibitory action in vitro 
against the micro-organisms commonly found in periodontics. Controls for assessing the quality of the 
drugs were carried out, quantifying phenols and flavonoids as chemical markers. Mouthwash solutions 
were formulated containing 0.1, 5 and 10% ethanol extract of R. officinalis; and 0.05, 5 and 10% of the 
hexane fraction of R. officinalis. In order to evaluate synergism, ethanol extract and hexane fraction were 
also added to formulations containing 0.05% sodium fluoride and 0.12% chlorhexidine digluconate. 
These formulations were assessed for inhibitory effect against the specific microorganisms involved 
in the process of bacterial plaque formation, S. mutans (ATCC25175) and C. albicans(ATCC 10231), 
frequently found in cases of oral infections. The agar diffusion method was used to evaluate the inhibitory 
activity of extracts and formulations. All mouthwash solutions displayed inhibitory activity having higher 
sensitivity to S. mutans for the 5% ethanol extract+0.05% sodium fluoride, and greater sensitivity to C. 
albicans for the 10% hexane fraction. Results were characterized by the appearance of a growth inhibition 
halo, justifying the utilization and association of extracts of R. officinalis.
Uniterms: Rosmarinus officinalis/pharmacognosy. Rosmarinus officinalis/Anti-microbial activity. 
Mouthwash. Periodontics/use of mouthwash. Medicinal plants.
Rosmarinus officinalis, pertencente à família Lamiaceae, é um exemplar da flora medicinal que possui 
propriedades terapêuticas. No intuito de usufruir destes benefícios, desenvolveu-se uma formulação 
de enxaguatório bucal com seleção criteriosa de matérias-primas que atendessem os requisitos 
farmacotécnicos. Incorporaram-se extratos dessa planta e verificou-se a capacidade inibitória in vitro 
frente a micro-organismos frequentemente encontrados em periodontias. Controles foram efetuados 
para a avaliação da qualidade dos fármacos, quantificando-se como marcadores químicos, os fenóis e os 
flavonóides. Formulações de enxaguatórios contendo 0,1, 5 e 10% de extrato etanólico de R. officinalis; e 
0,05, 5 e 10% da fração hexânica de R. officinalis foram preparadas. Para avaliar o sinergismo, o extrato 
e a fração hexânica também foram adicionados às formulações que continham fluoreto de sódio 0,05% 
e diguclonato de clorexidina 0,12%. Nessas formulações avaliou-se a capacidade inibitória frente a 
micro-organismos específicos do processo de formação de placa bacteriana, S. mutans (ATCC 25175) e 
C. albicans (ATCC 10231), frequentemente encontrada em quadros de infecções orais. Foi empregado 
o método de difusão em ágar para a avaliação da atividade inibitória dos extratos e das formulações. 
Todos os enxaguatórios demonstraram atividade inibitória, verificando-se maior sensibilidade a S. mutans, 
quando se utilizou extrato etanólico 5% + fluoreto de sódio 0,05% e sensibilidade maior a C. albicans, 
quando se utilizou fração hexânica a 10%. Os resultados foram caracterizados pelo aparecimento de 
halo de inibição de crescimento, justificando a utilização e associação dos extratos de R. officinalis.
Unitermos: Rosmarinus officinalis/farmacognosia. Rosmarinus officinalis/atividade antimicrobiana. 
Enxaguatório bucal. Periodontia/uso de enxaguatório bucal. Planta medicinal.
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INTRODUCTION
Rosmarinus officinalis belonging to the family 
Lamiaceae and popularly known as rosemary, has 
been widely used in folk medicine (Silva et al., 2008; 
Tressino, Gabriel, 2009). In the scientific community, it 
has demonstrated pharmacological action as a digestive, 
antispasmodic (Porte, Godoy, 2001), anti-inflammatory, 
anti-nociceptive (Takaki et al., 2008), anti-ulcer (Dias 
et al., 2000),hepatoprotective (Amim, Hamza, 2005), 
diuretic (Haloui et al., 2000) and antimicrobial (Newall, 
Anderson, Philipson, 2002; Silva et al., 2008), activities 
attributed to its various constituent phytochemicals 
(Sasaki et al., 2013).There are reports of the presence of 
neuroprotective activity for Alzheimer´s (Liu et al., 2009; 
Lin et al., 2010; El Omri et al., 2010) and Parkinson´s 
(Park et al., 2010) diseases, related to its major compounds 
including luteolin, carnosic acid and rosmarinic acid 
(Adams, Gmunder, Hamburguer, 2007).
Studies suggest potential of the antimicrobial effect 
of R. officinalis as a treatment for oral diseases (Bugno 
et al., 2006; Alvarenga et al., 2007; Bernardes et al., 
2010; Maekawa et al., 2010). Considering that the use 
of herbal products appears to be economically viable, 
it represents an interesting alternative and contributes 
toward improving the population’s access to solutions for 
the prevention and treatment of periodontal diseases. The 
aim of this study was to evaluate the antimicrobial activity 
of the extract and fractions of Rosmarinus officinalis, 
developing a mouthwash formulation with its extract, and 
to evaluate its synergism with substances currently used 
against dental biofilm.
MATERIAL AND METHODS
The leaves of Rosmarinus officinalis were collected 
from the Garden of Medicinal Plants of the Faculty of 
Pharmacy, at the Universidade Federal de Juiz de Fora. A 
voucher specimen was deposited in the Herbarium of the 
Botany Department of the Universidade Federal de Juiz de 
Fora (CESJ number 48253). The material was subjected to 
oven drying under forced ventilation for 48 hours at 37 °C 
and triturated with an industrial blender. The pulverized 
material was subjected to extraction by static maceration 
in ethanol PA for 48 hours at room temperature. After 
removing solvent by rotary-evaporation on a RII-Buchi 
Rotavapor®device, part of the dry ethanol extract was 
suspended in a solution of water: ethanol (9:1) followed by 
liquid-liquid partition with organic solvents of increasing 
polarity: hexane, dichloromethane, ethyl acetate and 
butanol. The suspension formed was again subjected to 
the rotavapor to remove the solvents, producing fractions 
of R. officinalis extract.
The determination of total phenols present in 
samples of the ethanol extract and in its fractions was 
performed with the Folin-Ciocalteu method (Sousa 
et al., 2007), using gallic acid as the standard. The 
quantification of levels of flavonoids was performed 
by the spectrophotometric method (Vennat et al., 1992; 
Sobrinho et al., 2008). In the reaction for quantification, 
reagents used were glacial acetic acid, pyridine:ethanol 
solutionand aluminum chloride solution. Rutin was the 
standard substance used for building the calibration curve, 
where data were subjected to linear regression analysis by 
the method of least squares, and the equation of the line 
and correlation coefficient were calculated (r).
For antimicrobial activity, minimum inhibitory 
concentration - MIC and minimum inhibitory concentration 
of adherence – MICA were determined using standard 
strains ofStreptococcus mutans ATCC 25175, lot 0307015 
and Candida albicans ATCC 10231, lot 030640006, both 
provided by the Reference Laboratory of Microorganisms 
Oswaldo Cruz Foundation, Rio de Janeiro. The microbial 
suspension used was standardized at 106 CFU/mL (colony 
forming units).
The culture media used for the determination of 
antimicrobial activity were: forS. mutans, TSA (Tryptic 
Soy Agar) with 24 hours of incubation and temperature of 
34 °C ±2, and forC. albicans, SDA (Sabouraud Dextrose 
Agar) with 48 hours of incubation at 25 °C±2. For the 
evaluation of MIC,BHI (Brain Heart Infusion) was used for S. 
mutans and SDB (Brain Sabouraud Dextrose) for C. albicans, 
whereas for MIC A, BHI supplemented with 5% sucrose was 
used; all under the same conditions of incubation.
Determination of antimicrobial activity was 
performed by the diffusion agar method (USP, 2009). 
The culture medium was placed in sterilized Petri dishes 
(20x100mm) to form a base layer of 15.0 mL. After 
solidification of the medium, 5.0mL of agar containing 1% 
inoculum of the microorganism were distributed across the 
base layer. Subsequently, stainless steel cylinders with an 
8 mm external diameter, 6mm internal diameter and height 
of 10 mm were placed in the center of the plate to receive 
the samples. After the incubation period, the full diameter 
of the inhibition zone was measured with calipers, without 
deducting the diameter of the cylinder.
MIC was determined in microliter plates containing 
a liquid medium using the method proposed by the CLSI 
(2009). The sample concentrations ranged from 5.0 to 
0.0025 mg/mL, and chlorhexidine (5.0 to 0.039 μg/mL) 
and miconazole nitrate (5.0 to 0,039 mg/mL) were used 
as controls.
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TABLE I - Mouthwash formulation with ethanol extract of R. officinalis
Components
Mouthwash formulation
A B C
Sodium benzoate 0.1% 0.1% 0.1%
Saccharin 0.1% 0.1% 0.1%
Propylene 15% 15% 15%
Disodium EDTA 0.05% 0.05% 0.05%
Mint Aroma q.s.t. q.s.t. q.s.t.
Ethanol extract Rosmarinus officinalis 0.1% 0.1% 0.1%
Sodium fluoride --- 0.05% ---
Chlorhexidine digluconate --- --- 0.12%
Water q.s.t. q.s.t. 100 mL q.s.t 100 mL q.s.t 100 mL
TABLE II - Phenol and flavonoid content in extracts and fractions of Rosmarinus officinalis
Samples Total phenols (g/100 g) ±SD Total flavonoids (g/100 g) ±SD
Ethanol extract 10.35 ± 0.2* 3.11 ± 0.1*
Hexane fraction 15.94 ± 0.2* 0.77 ± 0.03*
Dichloromethane fraction 7.45 ± 0.1* 0.43 ± 0.07*
Fraction in ethyl acetate 21.13 ± 0.09* 2.55 ± 0.06*
Buthanol fraction 2.28 ± 0.03* 0.43 ± 0.02*
*Mean ± Standard deviation of triplicate analysis.
The MICA of S. mutans for the surface was 
performed according to the methodology proposed by 
Freires et al., 2010. This test allows measurement of the 
lowest concentration of the sample able to inhibit the 
adherence of microorganism to glass, proving non-stick 
action of the extract in the presence of S. mutans. Sample 
concentrations were varied from 25 mg/mL to 3.12 to 
mg/mL, and chlorhexidine was used as the standard for 
concentrations from 100 µg/mL to 12.5 µg/mL.
The mouthwash was prepared according to Table I.
After manipulation of the formulation, an agar 
diffusion test was performed to observe its activity. 
A comparison with a white (base) formulation, which 
exhibited antimicrobial activity due to its preservatives, 
was performed in order to evaluate increased activities 
of formulations containing extracts and active products. 
There was also synergism between extract and fluoride 
sodium 0.05% and 0.12% chlorhexidine gluconate.
Tests were performed in triplicate, and each plate 
had a single test solution.
RESULTS AND DISCUSSION
The total phenolic content ranged from 2.28 to 
21.13 g/100 g in the extract and fractions of the Rosmarinus 
officinalis extract evaluated (Table II). Hexane fractions 
and ethyl acetate extracts showed higher total phenolic 
content when compared to the other products tested. Table 
II also shows that total flavonoid content ranged from 
0.43 to 3.11 g/100 g in both the extract and the fractions 
tested. The ethanol extract showed higher total flavonoids 
comparable to rutin. The variation of flavonoid levels in 
the fractions may be related to an increased amount of 
flavonoid non-glycosides, which are extracted in less polar 
solvents (Del Bano et al., 2004; Almeida et al., 2010).
The study of antimicrobial activity by the diffusion 
method showed that the ethanol extract and its fractions 
were effective in inhibiting the growth of S. mutans 
and C. albicans (Table III). This activity is attributed 
predominantly to the presence of phenolic constituents 
(Nascimento et al., 2000; Meléndez, Capriles, 2006).
Growth inhibition proved homogeneous, according 
to the degree of concentration of total phenols in samples of 
R. officinalis (Silva et al., 2008). These findings suggested 
the presence of bioactive compounds in the extract and 
fractions of rosemary with antimicrobial activity in vitro 
against Streptococcus mutans ATCC 25175 and Candida 
albicans ATCC 10231 strains.
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Meléndez, Capriles (2006) tested the methanol 
extract of leaves of R. officinalis against 17 strains of Gram 
positive and Gram negative bacteria, reporting activityfor 
10 strains and inhibition halos ranging from 12 to 18 mm.
For the ethanol extract and R. officinalis fractions,a 
result for the Minimum Inhibitory Concentration was 
obtained. After following the incubation time method 
indicated in the Methods section, some concentrations 
exhibited growth while others did not, findings that 
concurred with the results of the agar diffusion test, where 
both exhibited activity against the strain S. mutans ATCC 
25175 and C. albicans ATCC 10231 (Table IV).
The results were promising, since test values ranged 
from 0.312 mg/mL to 1.25 mg/mLfor the S. mutans strain 
and from 1.25 mg/mL to 2.5 mg/mL for the C. albicans 
strain.
These results proved to be consistent with previous 
studies assessing the MIC of essential oil and methanol 
extract of Rosmarinus officinalis for bacterial strains 
and Candida albicans, which obtained values higher 
than 900 µg/mL and from 2.5 to 10 mg/mL, respectively 
(Angioni et al., 2004; Celiktas, Bedir, Sukan, 2007).
Regarding the adherence test,defined as the lowest 
concentration of the extract able to inhibit the adherence 
of bacteria to glass after stirring, a MICA of 12.5 mg/mL 
was obtained for the ethanolic extract and 6.25 mg/mL for 
the fractions. The MICA for chlorhexidine was 25 µg/mL, 
since adherence of bacteria to glass occurred at the 
concentration of 12.5 mg/mL (Figure 1). The results for 
the samples and dilutions of chlorhexidine are given in 
Table V.
Currently, some plants are being researched to 
fight infections that affect the oral cavity, mainly caused 
by the presence of bacterial biofilms (Alves et al., 2009; 
Soares et al., 2007; Freireset al., 2010; Silva et al., 2012). 
Takarada et al. (2010) reported that rosemary essential oil 
TABLE III - Results of extent of inhibition halos (mm), obtained from tests with Rosmarinus officinalis extracts; in concentrations 
of 5 to 10% tested against S. mutans ATCC 25175 and C. albicans ATCC 10231
Samples
Extent of inhibition halos (mm) ±SD
5% 10%
S. mutans C. albicans S. mutans C. albicans
Ethanol extract 25 ± 0.2* 17 ± 0.2* 28 ± 0.1* 9.9 ± 0.08*
Hexane fraction 29 ± 0.06* 12 ± 0.2* 29 ± 0.1* 15 ± 0.2*
Dichloromethane fraction 20 ± 0.4* 9.3 ± 0.1* 21 ± 0.4* 9.5 ± 0.4*
Fraction in ethyl acetate 20 ± 0.3* 15 ± 0.03* 20 ± 0.2* 17 ± 0.2*
Buthanol fraction 14 ± 0.3* 16 ± 0.1* 15 ± 0.2* 10*
Ampicillin 1.0 mg/mL 30 ± 0.1* --- 30 ± 0.1* ---
DMSO Sh 13 ± 0.1* Sh 13 ± 0.1*
Miconazole nitrate 
1.0 mg / mL1.0 µg/mL --- 18 ± 0.1* --- 18 ± 0.1*
(---) Not applicable; (Sh) No inhibition halo.*Mean ± Standard deviation of triplicate analysis.
TABLE IV - Test results for MIC of ethanol extract and fractions of Rosmarinus officinalis, chlorhexidine and miconazole nitrate
Samples Streptococcus mutans Candida albicans
Ethanol Extract 0.625 mg/mL 1.25 mg/mL
Hexane fraction 0.312 mg/mL 1.25 mg/mL
Dichloromethane fraction 0.625 mg/mL 2.5 mg/mL
Fraction in ethyl acetate 0.625 mg/mL 1.25 mg/mL
Buthanol fraction 1.25 mg/mL 1.25 mg/mL
Chlorhexidine 12.5 µg/mL ---
Miconazole nitrate --- 0.312 mg/mL
 (---) Not applicable.
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TABLE V - MICA results against S. mutans ATCC 25175 strain 
for ethanol extract and Rosmarinus officinalis fractions and 
chlorhexidine
Samples MICA
Ethanol Extract 12.5 mg/mL
Hexane fraction 6.25 mg/mL
Dichloromethane fraction 6.25 mg/mL
Fraction in Ethyl Acetate 6.25 mg/mL
Buthanol fraction 6.25 mg/mL
Chlorhexidine 25 µg/mL
TABLE VI - Results of extent of inhibition halos (mm), obtained 
in studiesof mouthwash with ethanol extract of Rosmarinus 
officinalis, in concentrations of 0.1, 5 and 10% tested against S. 
mutans ATCC 25175 and C. albicans ATCC 10231 by the agar 
diffusion method
Mouthwash
Extent of inhibition halos (mm) ±SD
S. mutans C. albicans
A 29 ± 0.2* 15 ± 0.1*
B 30 ± 0.4* 20 ± 0.1*
C 29 ± 0.5* 16 ± 0.1*
WHITE A 20 ± 0.3* 10 ± 0.1*
WHITE B 27 ± 0.5* 16 ± 0.05*
WHITE C 28 ± 0.4* 14 ± 0.3*
*Mean ± Standard deviation of triplicate analysis. 
FIGURE 1 - MICA test against S. mutans ATCC 25175, positive control (A); fraction in Butanol of Rosmarinus officinalis in 
concentrations of 12.5 mg/mL and 6.25 mg/mL (B); and chlorhexidine in concentrations of 25 µg/mL and 12.5 µg/mL (C), 
respectively.
showed inhibitory effect on the adherence of S. mutans and 
inhibitory activity against the growth of Gram-negative 
bacteria (A. actinommycete comitans, P. gengivalis and 
F. nucleatum).
Given these studies, we suggest that the search for 
alternative therapies represents the main goal of research 
into the properties of plant extracts. Furthering the search 
for new alternatives, Minimum Inhibitory Concentration 
was tested for mouthwash formulations with ethanol 
extract (0.1%) and associations with sodium fluoride 
0.05% and 0.12% chlorhexidine (Figure 2). The activity 
of the formulations was evaluated using the agar diffusion 
method and the results are shown in Table VI.
Nascimento et al. (2000) proposed the association 
between antibiotics and plant extracts for resistant 
bacteria, indicating the occurrence of synergism, allowing 
ineffective antibiotics to exert action against bacteria.
Cordeiro et al. (2006) developed a mouthwash 
formulation containing an association with hydroalcoholic 
extracts of Rosmarinus officinalis (Rosemary), Plantago 
major (Tanchagem), Tebebuia impetignosa (Purple Ipe), 
Achillea millefolium (Yarrow) and Nasturtium officinale 
(Watercress). The formulation (with and without vegetable 
extracts) was tested against the following strains: S. 
aureus, B. subtilis, P. aeruginosa, E. coli and E. fecalis. 
The mouthwash exhibited activity, but no significant 
difference was observed between the formulations 
containing plant extracts and those without.
De-Carli et al. (2010), in a double-blind randomized 
clinical trial, tested the synergism between the propolis 
ethanol extract of (Apis mellifera) at 5% and Sodium 
Fluoride on the accumulation of dental biofilm. The 
association of propolis and fluoride enhanced the anticaries 
properties of fluorine through the chemical synergism, 
reducing biofilm formation and virulence of Streptococcus 
mutans, without changing the resident microflora.
The results of the present study corroborated those 
of the cited studies, having demonstrated antimicrobial, 
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anti-adherent and synergetic activities for the extract and 
fractions of R. officinalis tested.
CONCLUSION
The results obtained by these methods allow us to 
conclude that the extract and fractions of R. officinalis 
exert activity against micro-organisms affecting the oral 
cavity and, when incorporated into the formulations 
of mouthwash, showed synergism with the substances 
currently used, indicating a promising product. However, 
further studies must be performed to enhance efficacy 
and safety.
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